Xeroderma pigmentosum (XP) is a rare genetic disorder. It causes hypersensitivity to ultraviolet (UV) light, eye problems and neurological symptoms. XP occurs because of a gene change (mutation) you inherit from your parents. There’s no cure for XP, but treatment can lower your risk of skin cancer and other complications.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Xeroderma pigmentosum (XP) is a rare genetic disorder that causes hypersensitivity to ultraviolet (UV) light. Symptoms usually affect the parts of your body that are regularly exposed to the sun, such as your face, arms and lips. People with XP usually start showing symptoms in early childhood. They may get blistering sunburns after even just a few minutes in the sun.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
No. Xeroderma pigmentosum isn’t cancer, but it can increase your risk of developing skin cancer.
People with XP develop sunburns easily and have a higher risk of skin cancer. Compared to those with average risk, people with XP have:
Some reports have also found that people with XP are more likely to develop cancers such as:
Xeroderma pigmentosum is rare. Experts estimate about 1 in 1 million people in the United States and Europe have XP.
It’s more common in other parts of the world, occurring in around 1 in 22,000 people in Japan. It’s also more common in North Africa and the Middle East.
Symptoms of XP can vary but usually affect your skin, eyes and nervous system.
Skin symptoms may include:
Advertisement
People with XP also have an increased risk of precancerous skin lesions called actinic keratoses.
Eye symptoms usually affect people with XP before age 10. These symptoms may include:
Over time, these symptoms may cause vision loss or even blindness. People with XP also have a higher risk of developing eye cancers.
Xeroderma pigmentosum can also affect your nervous system. About 1 in 4 people with XP develop neurological symptoms such as:
Experts think these symptoms develop because of a loss of nerve cells in your brain.
Xeroderma pigmentosum is a genetic disorder, meaning it occurs because of atypical gene changes (mutations). You inherit these gene mutations from one or both parents.
Your healthcare providers may suspect XP based on your symptoms. They use a blood test to confirm a diagnosis of XP. The blood test checks for the gene mutations that cause xeroderma pigmentosum.
There’s no cure for xeroderma pigmentosum. But your healthcare provider may give you treatment options to reduce symptoms, including:
There’s no way to prevent XP. If your physician suspects you have the gene mutation that causes XP, you may choose to have genetic testing.
A genetic test tells you if you have the gene mutation. A genetic counselor reviews the results with you and helps you understand the associated risks, including the chances of having a child with XP.
If you have xeroderma pigmentosum, you need to take several steps to manage your overall health, including:
Advertisement
Advertisement
The life expectancy for xeroderma pigmentosum can vary. Many people with the condition have a shortened lifespan from developing skin cancer at a very young age. Taking steps to prevent sun damage early in life can increase the chances of living longer.
If you or your child has xeroderma pigmentosum, or you think you could, you may want to ask your healthcare provider:
A note from Cleveland Clinic
Xeroderma pigmentosum (XP) is a rare genetic disorder. The most common symptom is hypersensitivity to UV rays. Many people also have symptoms that affect their eyes and their neurological development. If you have XP, it’s crucial to avoid UV light as much as possible. Protecting your skin from the sun and regular skin cancer screenings increase your chances of a favorable outlook.
Advertisement
Last reviewed on 08/31/2022.
Learn more about the Health Library and our editorial process.